First, IL-27 expression profile correlates with tumor progression : whereas IL-27 is not expressed in benign melanocytic lesions nor in the least aggressive forms of malignant melanoma, it is expressed at a higher frequency in advanced stages of primary cutaneous melanomas and this expression is maintained in metastatic lesions. This evidence concerns the gene IL27 and neoplasm.